Celsius Therapeutics, Janssen Biotech Form Biomarker Discovery Alliance

Jul 09, 2019

|

NEW YORK — Celsius Therapeutics said today that it has signed an agreement to help Johnson & Johnson subsidiary Janssen Biotech identify drug response biomarkers for an investigational ulcerative colitis drug combination.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Not Going for the Move

NPR reports that many USDA researchers working at the two agencies that are relocating to the Kansas City area are declining to go.

And Overturned

Genetic genealogy has helped exonerate a man who has been jailed for 20 years, Agence France Presse reports.

Food for Billions More

A new report says genetically modified food might be necessary to be able to feed a planet of nearly 10 billion people, Bloomberg says.

Nature Examines New RNA Editing Approach, Musa Balbisiana Genome, More

In Nature this week: new RNA editing approach called LEAPER, draft assembly of Musa balbisiana banana genome, and more.

Featured White Papers

Cell Engineering 101

CRISPR 101

Gene Knockouts: How CRISPR Is Used to Inactivate Genes

BlueBee Data Security & Compliance

Jul

23

Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.

Jul

30

Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Jul

31

Featured Webinar

Considerations and Impact of Implementing Targeted NGS in Myeloid Malignancies

This webinar will provide a first-hand look at how a molecular laboratory validated and implemented a targeted next-generation sequencing-based myeloid assay to expedite the assessment of myeloid malignancies and assist in the understanding of myeloid cancers.

Aug

29

Featured Webinar

Biobanking at Scale to Support Precision Medicine

This webinar will outline how RUCDR Infinite Biologics, the world's largest university-based biorepository, has implemented workflows and processes to support precision medicine applications.

Menu